相似文献
1
Echocardiography in the acute phase of COVID-19 infection: impact on management and prognosis.
Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):532-535. doi: 10.1016/j.rec.2021.11.012. Epub 2021 Dec 14.
2
The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact.
Monaldi Arch Chest Dis. 2020 May 19;90(2). doi: 10.4081/monaldi.2020.1358.
3
The clinical and prognostic role of echocardiography in 'SARS-CoV-2' disease.
Eur J Emerg Med. 2021 Aug 1;28(4):321-323. doi: 10.1097/MEJ.0000000000000795.
4
Echocardiographic Manifestations in COVID-19: A Review.
Heart Lung Circ. 2021 Aug;30(8):1117-1129. doi: 10.1016/j.hlc.2021.02.004. Epub 2021 Feb 19.
5
Adapting the role of handheld echocardiography during the COVID-19 pandemic: A practical guide.
Perfusion. 2021 Sep;36(6):547-558. doi: 10.1177/0267659120986532. Epub 2021 Jan 9.
6
The usefulness of speckle tracking echocardiography in identifying subclinical myocardial dysfunction in young adults recovered from mild COVID-19.
Echocardiography. 2022 Sep;39(9):1190-1197. doi: 10.1111/echo.15431. Epub 2022 Jul 29.
7
Cardiac manifestations of COVID-19 infection: the role of echocardiography in patient management.
Infection. 2021 Feb;49(1):187-189. doi: 10.1007/s15010-020-01507-3. Epub 2020 Aug 24.
8
Cardiac Characteristics of the First Two Waves of COVID-19 in Denmark and the Prognostic Value of Echocardiography: The ECHOVID-19 Study.
Cardiology. 2023;148(1):48-57. doi: 10.1159/000528308. Epub 2022 Dec 1.
9
Monthly transthoracic echocardiography in young adults for 6 months following SARS-CoV-2 infection.
Physiol Rep. 2023 Jan;11(1):e15560. doi: 10.14814/phy2.15560.
10
Using TAPSE (tricuspid annular plane systolic excursion) as a predictor of poor prognosis of COVID-19: is it enough?
Int J Infect Dis. 2021 Jun;107:164. doi: 10.1016/j.ijid.2021.04.056. Epub 2021 Apr 22.
本文引用的文献
1
Myocardial Inflammation and Dysfunction in COVID-19-Associated Myocardial Injury.
Circ Cardiovasc Imaging. 2021 Jan;14(1):e012220. doi: 10.1161/CIRCIMAGING.120.011713. Epub 2021 Jan 19.
2
Cardiac imaging phenotype in patients with coronavirus disease 2019 (COVID-19): results of the cocarde study.
Int J Cardiovasc Imaging. 2021 Feb;37(2):449-457. doi: 10.1007/s10554-020-02010-4. Epub 2020 Sep 9.
3
Echocardiographic findings in critical patients with COVID-19.
Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):861-863. doi: 10.1016/j.rec.2020.06.030. Epub 2020 Jul 30.
4
Indications for and Findings on Transthoracic Echocardiography in COVID-19.
J Am Soc Echocardiogr. 2020 Oct;33(10):1278-1284. doi: 10.1016/j.echo.2020.06.009. Epub 2020 Jun 17.
5
COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel.
Eur Heart J Cardiovasc Imaging. 2020 Jun 1;21(6):592-598. doi: 10.1093/ehjci/jeaa072.
6
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.
JAMA Cardiol. 2020 Jul 1;5(7):802-810. doi: 10.1001/jamacardio.2020.0950.
Zotero 插件